KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Invested Capital (2016 - 2025)

Pfizer (PFE) has disclosed Return on Invested Capital for 17 consecutive years, with 0.58% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Invested Capital fell 45.0% to 0.58% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.58%, a 45.0% decrease, with the full-year FY2024 number at 0.4%, down 53.0% from a year prior.
  • Return on Invested Capital was 0.58% for Q2 2025 at Pfizer, up from 0.77% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.39% in Q4 2022 to a low of 0.77% in Q1 2025.
  • A 5-year average of 0.08% and a median of 0.03% in 2023 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: increased 22bps in 2021, then crashed -75bps in 2025.
  • Pfizer's Return on Invested Capital stood at 0.22% in 2021, then skyrocketed by 76bps to 0.39% in 2022, then tumbled by -258bps to 0.61% in 2023, then dropped by -19bps to 0.73% in 2024, then rose by 20bps to 0.58% in 2025.
  • Per Business Quant, the three most recent readings for PFE's Return on Invested Capital are 0.58% (Q2 2025), 0.77% (Q1 2025), and 0.73% (Q4 2024).